Development of a high throughput, molecular diagnostic assay for predicting telomerase activity in breast cancer cell lines and tissues
Lynne W. Elmore(Virginia Commonwealth University), Shelby Holt(Southwestern Medical Center), Ali Akalin(University of Richmond), Andrea Ferreira‐Gonzalez, M Grimes(University of Richmond), Carleton T. Garrett(University of Richmond), Lauren Gollahon(Texas Tech University), G Clarke(Baylor College of Medicine), R. Tucker Burks(University of Richmond)
Cited by 0
Related Papers
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|514